Sixteen understudied kinases showed strong variance between TNBC and HER2/luminal breast cancer, with higher-ranked understudied kinases being DAPK3, ADCK1, MRCKA (CDC42BPA), STK17A, DMPK and VRK2. This evidence concerns the gene DMPK and breast carcinoma.